Comparing Lamotrigine vs Depakene
Lamotrigine | Depakene (valproic acid) |
|
---|
Lamotrigine | Depakene (valproic acid) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Lamotrigine is used to decrease the frequency and severity of seizures in some types of epilepsy and also to stabilize mood in bipolar I disorder. It is an oral tablet that is taken once or twice a... View more |
Prescription only
Prescribed for Epilepsy, Seizure Prevention, Seizures. Depakene may also be used for purposes not listed in this medication guide. |
Related suggestions Seizures
Seizure Prevention (Seizure Prophylaxis)
|
|||||||
More about Lamotrigine | More about Depakene (valproic acid) | ||||||||
Ratings & Reviews | |||||||||
Lamotrigine has an average rating of 7.8 out of 10 from a total of 1841 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 15% reported a negative effect. |
Depakene has an average rating of 5.7 out of 10 from a total of 10 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 30% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Lamotrigine side effects |
View all Depakene side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic |
Lower cost generic approved | ||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Lamotrigine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
Lamictal, Lamictal CD, Lamictal ODT, Lamictal XR, Subvenite | Other valproic acid brands include: Valproate Sodium | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
25.7 hours |
16 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
When Treating Epilepsy
Category X
Not for use in pregnancy
When Treating Migraine See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 286 drugs are known to interact with Lamotrigine:
|
A total of 425 drugs are known to interact with Depakene:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
December 27, 1994 |
February 28, 1978 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.